The COPD control panel: towards personalised medicine in COPD

Alvar Agusti; William MacNee

doi:10.1136/thoraxjnl-2012-202772

The COPD control panel: towards personalised medicine in COPD

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease whose assessment and management have traditionally been based on the severity of airflow limitation (forced expiratory volume in 1 s (FEV1)). Yet, it is now clear that FEV1 alone cannot describe the complexity of the disease. In fact, the recently released Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011 revision has proposed a new combined assessment method using three variables (symptoms, airflow limitation and exacerbations).

Original language	English
Pages (from-to)	687-90
Number of pages	4
Journal	Thorax
Volume	68
Issue number	7
DOIs	https://doi.org/10.1136/thoraxjnl-2012-202772
Publication status	Published - Jul 2013

Keywords / Materials (for Non-textual outputs)

Disease Management
Forced Expiratory Volume
Humans
Individualized Medicine
Prognosis
Pulmonary Disease, Chronic Obstructive
Respiratory Function Tests
Severity of Illness Index

Access to Document

10.1136/thoraxjnl-2012-202772

Cite this

@article{40fe2f16953446a48dc8f812999d8183,

title = "The COPD control panel: towards personalised medicine in COPD",

abstract = "Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease whose assessment and management have traditionally been based on the severity of airflow limitation (forced expiratory volume in 1 s (FEV1)). Yet, it is now clear that FEV1 alone cannot describe the complexity of the disease. In fact, the recently released Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011 revision has proposed a new combined assessment method using three variables (symptoms, airflow limitation and exacerbations).",

keywords = "Disease Management, Forced Expiratory Volume, Humans, Individualized Medicine, Prognosis, Pulmonary Disease, Chronic Obstructive, Respiratory Function Tests, Severity of Illness Index",

author = "Alvar Agusti and William MacNee",

year = "2013",

month = jul,

doi = "10.1136/thoraxjnl-2012-202772",

language = "English",

volume = "68",

pages = "687--90",

journal = "Thorax",

issn = "0040-6376",

publisher = "BMJ Publishing Group",

number = "7",

}

TY - JOUR

T1 - The COPD control panel

T2 - towards personalised medicine in COPD

AU - Agusti, Alvar

AU - MacNee, William

PY - 2013/7

Y1 - 2013/7

N2 - Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease whose assessment and management have traditionally been based on the severity of airflow limitation (forced expiratory volume in 1 s (FEV1)). Yet, it is now clear that FEV1 alone cannot describe the complexity of the disease. In fact, the recently released Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011 revision has proposed a new combined assessment method using three variables (symptoms, airflow limitation and exacerbations).

AB - Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease whose assessment and management have traditionally been based on the severity of airflow limitation (forced expiratory volume in 1 s (FEV1)). Yet, it is now clear that FEV1 alone cannot describe the complexity of the disease. In fact, the recently released Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011 revision has proposed a new combined assessment method using three variables (symptoms, airflow limitation and exacerbations).

KW - Disease Management

KW - Forced Expiratory Volume

KW - Humans

KW - Individualized Medicine

KW - Prognosis

KW - Pulmonary Disease, Chronic Obstructive

KW - Respiratory Function Tests

KW - Severity of Illness Index

U2 - 10.1136/thoraxjnl-2012-202772

DO - 10.1136/thoraxjnl-2012-202772

M3 - Article

C2 - 23117977

SN - 0040-6376

VL - 68

SP - 687

EP - 690

JO - Thorax

JF - Thorax

IS - 7

ER -

The COPD control panel: towards personalised medicine in COPD

Abstract / Description of output

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Cite this